Pedea Unión Europea - islandés - EMA (European Medicines Agency)

pedea

recordati rare diseases - Íbúprófen - slagæðarásar, einkaleyfi - hjarta meðferð - meðferð á blóðfrumumyndandi einkaleyfalyfjum í nýburum yngri en 34 vikna meðgöngutíma.

Livostin Augndropar, dreifa 0,5 mg/ml Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

livostin augndropar, dreifa 0,5 mg/ml

mcneil sweden ab - levocabastinum hýdróklóríð - augndropar, dreifa - 0,5 mg/ml

Kenacort-T Stungulyf, dreifa 40 mg/ml Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

kenacort-t stungulyf, dreifa 40 mg/ml

bristol-myers squibb ab - triamcinolonum acetóníð - stungulyf, dreifa - 40 mg/ml

Azithromycin STADA Mixtúruduft, dreifa 40 mg/ml Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

azithromycin stada mixtúruduft, dreifa 40 mg/ml

stada arzneimittel ag - azithromycinum díhýdrat - mixtúruduft, dreifa - 40 mg/ml

Zitromax Mixtúruduft, dreifa 40 mg/ml Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

zitromax mixtúruduft, dreifa 40 mg/ml

pfizer aps - azithromycinum díhýdrat - mixtúruduft, dreifa - 40 mg/ml

VaxigripTetra Stungulyf, dreifa í áfylltri sprautu 15 míkróg Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

vaxigriptetra stungulyf, dreifa í áfylltri sprautu 15 míkróg

sanofi pasteur* - a/victoria/2570/2019 (h1n1)pdm09 - líkur stofn (a/victoria/2570/2019, ivr-215); a/darwin/9/2021 (h3n2) - líkur stofn (a/darwin/9/2021, ivr-228); b/austria/1359417/2021 - líkur stofn (b/michigan/01/2021, villigerð); b/phuket/3073/2013-líkur stofn (b/phuket/3073/2013, villigerð) - stungulyf, dreifa í áfylltri sprautu - 15 míkróg